Navigation Links
Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
Date:5/14/2012

DRAPER, Utah, May 14, 2012 /PRNewswire/ -- Flexpoint Sensor Systems, Inc. (OTCBB: FLXT) http://www.flexpoint.com, a leader in design and supply of thin film sensing technology, announced today that they have received a purchase order for the a disposable colonoscope device.

The purchase order will advance the development of a disposable directional positioning sensor for colonoscopes and follows the successful testing of the original prototypes. Annual demand for colonoscopy ranges from 2.21 to 7.96 million procedures in the United States, according to an article published in MedScape Today magazine. One of the difficulties with the procedure is providing an inexpensive means of locating the exact position of the colonoscopes.  With the use of a sensor array and monitoring equipment it appears to be possible to locate the positioning of the colonoscopes. 

"In March, we announced we were working on developing this product and have now advanced to the stage of receiving a purchase order for working prototypes of this product," said Flexpoint President Clark Mower. "The development to date shows significant promise and this purchase order is an advancement of the early prototype development and testing stage. Prior work on this technology has gone well and the client is anxious to move the development, testing and approval process along as quickly as possible.  Since it is a medical application, it will have to go through a rigorous testing process before final approvals are received.  Assuming the testing and approval process occurs as anticipated; this product could gain wide scale usage as early as the second half of 2013 and be used in a high percentage of all colonoscopies." 

Mower continued, "I also want to provide more clarity on our May 9th announcement.  We are currently working with a major truck manufacturer.  They are currently distributing RFQ's to Tier 1 manufacturers for a product that they will OEM.  The RFQ is for the manufacture of the entire integrated component, but Flexpoint's sensor is a required component included in all the RFQ's.  It is anticipated that during the next few weeks a decision will be made on the Tier 1 manufacturer and we look forward to supplying the selected supplier in this process with our sensors for their production.  Flexpoint anticipates each new system to be integrated with the Bend Sensor® with annual volumes in excess of 80,000."

About Flexpoint

Flexpoint Sensor Systems (FLXT) is a leading supplier of thin film sensing technology to many industries, including automotive, medical, industrial controls, and consumer products.

Flexpoint manufactures a patented new flexible sensor that has also proven to be an extremely durable switch. The single layer Bend Sensor® product allows for the measurement of mechanical movement, air flow, water flow, or even vibration. In addition, it has been tested to over 35 million cycles without failure. It can be used as a range of motion sensor, or as a very durable, very reliable switch in most harsh environments. The breadth of applications for our sensor is limited only by one's imagination.

Forward-Looking Statements

This press release contains certain forward-looking statements.  Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Flexpoint Sensor Systems
Clark Mower, President, 801-568-5111

Brokers and Analysts:
Chesapeake Group
410-825-3930


'/>"/>
SOURCE Flexpoint Sensor Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , Feb. 27, 2017   Royal ... PHIA), a global leader in health technology, today ... Drug Administration (FDA) to market its ElastQ Imaging ... family of ultrasound systems. ElastQ Imaging enables simultaneous ... which is essential for the diagnosis of various ...
(Date:2/27/2017)... PLACENTIA, Calif. , Feb. 27, 2017   ... new line of nutritional supplements using its groundbreaking new ... and 90 percent of potency through digestion per ... nutritional supplements solve the problem of nutritional waste and ... Prevent degradation during digestive processes Improve ...
(Date:2/27/2017)... FORT WASHINGTON, Pa. , Feb. 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... the following upcoming investor conferences. Raymond James ... a.m. ET on March 6, 2017 in Orlando, FL. ... Care Conference at 8:00 a.m. ET on March 7, 2017 in ... at 8:30 a.m.ET on March 16, 2017 in Miami, FL. ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Hotze ... industry, announces Chris Brandl as its New Guest Director. , Brandl is ... corporations throughout his career. He began his professional career at Omnium Worldwide, now ...
(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been ... women who become dependent on opioid painkillers has fallen short. From 1999 until 2010, ... a 237% increase in fatal overdoses in male populations.(1) , The proportion of women ...
(Date:2/27/2017)... ... February 27, 2017 , ... Orange County dentist, ... inflammatory gum condition that occurs when the bacteria in plaque infect the gums and ... as a scaling and root planing or SRP, and can include surgical therapies if ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the ... studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society of ... Liegner, M.D. has compiled into a single volume a compelling argument that the disease ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... announce a new informational post on robotic hair transplantation. San Francisco residents may ... transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be ...
Breaking Medicine News(10 mins):